<DOC>
	<DOCNO>NCT02538003</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability LCB01-0371 fasting/non-fasting food take healthy male subject .</brief_summary>
	<brief_title>To Evaluate Effect Food Pharmacokinetics ( PK ) , Phase I Clinical Study LCB01-0371</brief_title>
	<detailed_description>A Randomized , Open-label , Single dose , Crossover , Phase â…  Trial evaluate effect food pharmacokinetics LCB01-0371 healthy male subject .</detailed_description>
	<criteria>1 . Healthy male 20 40 year age time screen body mass index ( BMI ) 19 kg/m2 28 kg/m2 time screen 2 . Appropriated medical examination interview , Vital sign , physical examination , local laboratory test result 12lead ECG 3 . Capable perform follow visit , blood sample 4 . Agree continue use medically reliable dual contraception donate sperm protocol duration study 28 day last dose investigational product 5 . Capable give write informed consent , willing participate clinical trial , willing comply study requirement 1 . History clinically significant disease digestive system , respiratory , musculoskeletal , cardiovascular , endocrine , neuropsychiatry , hematology , cardiovascular system 2 . History gastrointestinal problem ( e.g . Crohn 's disease , gastrointestinal ulcer ) within 180 day possibly affect absorption clinical trial drug , history surgery ( except simple appendectomy herniotomy ) 3 . History hypersensitivity reaction history clinically significant hypersensitivity reaction LCB010371 class study drug ( linezolid ) drug include aspirin antibiotic ( except non active allergic rhinitis ) 4 . History drug abuse positive result urine drug screen test screen visit 5 . Intake drug expect chronic influence drug absorption elimination within 30 day prior screen visit 6 . Other : Patients consider unable perform study investigator concern</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>